It has been reported that RACK1 could participate in the lymphangiogenesis and LN metastasis of cervical cancer in a Galectin-1-dependent manner [11], suggesting that targeting RACK1 may be a promising strategy. This evidence concerns the gene RACK1 and cervical cancer.